Blue Chip Wealth Management’s AbbVie ABBV Stock Holding History

Blue Chip Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$699K	Buy	7,981 +738	+10%	+$69.5K	0.55%	43
2020 Q2	$711K	Buy	7,243 +1,100	+18%	+$96.8K	0.67%	41
2020 Q1	$468K	Buy	6,143 +703	+13%	+$59.9K	0.58%	48
2019 Q4	$482K	Buy	5,440 +1,228	+29%	+$102K	0.45%	57
2019 Q3	$319K	Buy	4,212 +806	+24%	+$55.3K	0.33%	70
2019 Q2	$248K	Buy	3,406 +20	+0.6%	+$1.57K	0.26%	85
2019 Q1	$273K	Sell	3,386 -132	-4%	-$10.8K	0.31%	77
2018 Q4	$324K	Sell	3,518 -26	-0.7%	-$2.29K	0.43%	61
2018 Q3	$335K	Sell	3,544 -334	-9%	-$31.7K	0.34%	72
2018 Q2	$359K	Buy	3,878 +207	+6%	+$20.2K	0.39%	68
2018 Q1	$347K	Buy	+3,671	New	+$403K	0.36%	66

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Blue Chip Wealth Management's ABBV Position: Q3 2020 in Review

Blue Chip Wealth Management increased its AbbVie (ABBV) stake by 10% in Q3 2020, buying an estimated $69.5K and bringing the position to 7,981 shares worth $699K. The position accounts for 0.55% of the portfolio, ranked #43.

Blue Chip Wealth Management first reported a position in ABBV in Q1 2018 and has held it in 11 quarters since. The position peaked at $711K in Q2 2020. 2,366 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

Blue Chip Wealth Management held 7,981 shares of AbbVie worth $699K as of Q3 2020.
Blue Chip Wealth Management bought 738 AbbVie shares in Q3 2020, an estimated $69.5K.
AbbVie made up 0.55% of Blue Chip Wealth Management's portfolio in Q3 2020, its #43 holding.
Blue Chip Wealth Management first reported a position in AbbVie in Q1 2018 and has held it in 11 quarters since.
Blue Chip Wealth Management's AbbVie position peaked at $711K in Q2 2020.
2,366 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Blue Chip Wealth Management's 13F filing for Q3 2020, filed 12 Nov 2020.